341 related articles for article (PubMed ID: 33924474)
1. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG
Kamali S; Rajendran R; Stadelmann C; Karnati S; Rajendran V; Giraldo-Velasquez M; Berghoff M
Brain Pathol; 2021 Mar; 31(2):297-311. PubMed ID: 33103299
[TBL] [Abstract][Full Text] [Related]
3. Oligodendrocyte-Specific Deletion of
Rajendran R; Rajendran V; Giraldo-Velasquez M; Megalofonou FF; Gurski F; Stadelmann C; Karnati S; Berghoff M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502405
[TBL] [Abstract][Full Text] [Related]
4. Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation.
Rajendran R; Giraldo-Velásquez M; Stadelmann C; Berghoff M
Brain Pathol; 2018 Mar; 28(2):212-224. PubMed ID: 28117910
[TBL] [Abstract][Full Text] [Related]
5. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
6. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
7. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
[TBL] [Abstract][Full Text] [Related]
8. The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
Rawji KS; Yong VW
Clin Dev Immunol; 2013; 2013():948976. PubMed ID: 23840244
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.
Kerstetter AE; Padovani-Claudio DA; Bai L; Miller RH
Exp Neurol; 2009 Nov; 220(1):44-56. PubMed ID: 19616545
[TBL] [Abstract][Full Text] [Related]
10. The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis.
Rajendran R; Rajendran V; Böttiger G; Stadelmann C; Shirvanchi K; von Au L; Bhushan S; Wallendszus N; Schunin D; Westbrock V; Liebisch G; Ergün S; Karnati S; Berghoff M
Br J Pharmacol; 2023 Dec; 180(23):2989-3007. PubMed ID: 37400950
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Kumar S; Patel R; Moore S; Crawford DK; Suwanna N; Mangiardi M; Tiwari-Woodruff SK
Neurobiol Dis; 2013 Aug; 56():131-44. PubMed ID: 23603111
[TBL] [Abstract][Full Text] [Related]
12. Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes.
Rajendran R; Böttiger G; Dentzien N; Rajendran V; Sharifi B; Ergün S; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 May; 10(6):. PubMed ID: 34070622
[TBL] [Abstract][Full Text] [Related]
13. Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis.
Rajendran R; Rajendran V; Gupta L; Shirvanchi K; Schunin D; Karnati S; Giraldo-Velásquez M; Berghoff M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293040
[TBL] [Abstract][Full Text] [Related]
14. Promotion of microglial phagocytosis by tuftsin stimulates remyelination in experimental autoimmune encephalomyelitis.
Bao Z; Hao J; Li Y; Feng F
Mol Med Rep; 2019 Dec; 20(6):5190-5196. PubMed ID: 31702807
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.
Evonuk KS; Baker BJ; Doyle RE; Moseley CE; Sestero CM; Johnston BP; De Sarno P; Tang A; Gembitsky I; Hewett SJ; Weaver CT; Raman C; DeSilva TM
J Immunol; 2015 Jul; 195(2):450-463. PubMed ID: 26071560
[TBL] [Abstract][Full Text] [Related]
16. Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
Mokhtarian F; Safavi F; Sarafraz-Yazdi E
Brain Res; 2012 Dec; 1488():92-103. PubMed ID: 23031637
[TBL] [Abstract][Full Text] [Related]
17. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
Bhasin M; Wu M; Tsirka SE
BMC Immunol; 2007 Jul; 8():10. PubMed ID: 17634104
[TBL] [Abstract][Full Text] [Related]
18. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis.
Zhao PY; Wang YQ; Liu XH; Zhu YJ; Zhao H; Zhang QX; Qi F; Li JL; Zhang N; Fan YP; Li KN; Zhao YY; Lei JF; Wang L
J Ethnopharmacol; 2018 May; 217():36-48. PubMed ID: 29428242
[TBL] [Abstract][Full Text] [Related]
19. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
Wen J; Ribeiro R; Tanaka M; Zhang Y
Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
[TBL] [Abstract][Full Text] [Related]
20. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L
Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
